Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DATiC: PK of TB and ARV Drugs in Children
NCT01637558Phase 4Completed
- Sponsor
- University of Cape Town
- Start
- Nov 2012
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of isoniazid, rifampicin, pyrazinamide, ethambutol, lopinavir + ritonavir in Tuberculosis (TB), human immunodeficiency virus infection (HIV), sponsored by University of Cape Town. Started Nov 2012; status: completed.
02
Drugs
isoniazidrifampicinpyrazinamideethambutollopinavir + ritonavir
03
Conditions
Tuberculosis (TB)human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01637558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01637558.